Bioasis Technologies Inc. V.BTI

NEW CORPORATE PRESENTATION (TIMELINES)

[AlfredSisley]

https://www.bioasis.us/investors/

[barsax]

is slide 45 new? also slides 53, 54?  (FTD)

[MineDigger]

for 45, Doxorubicin Conjugate, see was 48 in July 2020 presentation but 53 and 54 (and 55), "Progranulin" is a word that has never been used before in the few corporate presentations and NRs I have downloaded.

[barsax]

this presentation was created for the BIO Europe virtual conference that took place earlier...hence the October date on the presentation.  From what we can see BTI has a new drug: XB3 combined with Progranulin, potentially for the treatment of Frontotemporal Dementia.